A trend toward improved survival with RAS in high-risk subgroups, such as patients with T4b tumors, has been reported, but failed to reach statistical significance [ 36 ].
1
—
—
A trend toward improved survival with RAS in high-risk subgroups, such as patients with T4b tumors, has been reported, but failed to reach statistical significance [ 36 ].